| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 605756 | Null | 0.00397405528023196 | 0.22973907 |
| NSC 618262 | Null | 0.00397405528023196 | 0.13790136 |
| NSC 633530 | 1H-Pyrido[3,4-b]indol-1-one, 2,3,4,9-tetrahydro-2-[4-(4- phenyl-1-piperazinyl)butyl]-9-methyl- | 0.00397405528023196 | 0.18048211 |
| NSC 647751 | Null | 0.00397405528023196 | 0.15911616 |
| NSC 671898 | Null | 0.00397405528023196 | -0.34930723 |
| NSC 690271 | ANTINEOPLASTIC-690271 | 0.00397405528023199 | 0.14383963 |
| NSC 69187 | B 656501 K003 | 0.00397405528023199 | 0.25020475 |
| NSC 281818 | Ethanol, 2,2'-[[3-methyl-4-[[[4-[2-(4-propoxyphenyl]-4-thiazolyl]phenyl]imino]methyl]phenyl]imino]bis-, dimethanesulfonate (ester) | 0.00426229108513041 | 0.061204043 |
| NSC 620327 | Carbonimidodithioic acid, [5-(4-nitrophenyl)-1,3,4- thiadiazol-2-yl]-, dimethyl ester | 0.00426229108513041 | -0.1037643 |
| NSC 637921 | 1H-Pyrazole-1-propanamide, 3,5-diphenyl- N-(4-methoxyphenyl)-4-[(4-methylphenyl)azo]-.beta.-oxo- | 0.00426229108513041 | -0.30444846 |